For the year ending 2025-12-31, TFX had $126,199K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net (loss) income | -905,640 |
| Loss (income) from discontinued operations | -964,170 |
| Depreciation expense | 56,082 |
| Intangible asset amortization expense | 121,656 |
| Deferred financing costs and debt discount amortization expense | 4,675 |
| Gain on non-designated foreign currency forward contracts | 82,636 |
| Pension settlement charge | 0 |
| Changes in contingent consideration | 16,446 |
| Asset impairments | 108,117 |
| Stock-based compensation | 25,695 |
| Gain on sale of assets and business | 0 |
| Deferred income taxes, net | -100,967 |
| Payments for contingent consideration | 0 |
| Interest benefit on swaps designated as net investment hedges | 22,220 |
| Other | -7,608 |
| Accounts receivable | 85,533 |
| Inventories | -84,041 |
| Prepaid expenses and other assets | 35,585 |
| Accounts payable, accrued expenses and other liabilities | -8,284 |
| Income taxes | -35,727 |
| Net cash provided by operating activities from continuing operations | 96,682 |
| Expenditures for property, plant and equipment | 95,236 |
| Payments for businesses and intangibles acquired, net of cash acquired | 831,857 |
| Proceeds on non-designated balance sheet hedges | 82,203 |
| Proceeds from sales of business and assets | 6,712 |
| Insurance settlement proceeds | 9,447 |
| Net interest proceeds on swaps designated as net investment hedges | 21,078 |
| Proceeds from sales of investments | 0 |
| Purchase of investments | 5,000 |
| Net cash (used in) provided by investing activities from continuing operations | -812,653 |
| Proceeds from new borrowings | 1,140,000 |
| Reduction in borrowings | 153,000 |
| Debt extinguishment, issuance and amendment fees | 4,961 |
| Repurchase of common stock | 300,000 |
| Net proceeds from share based compensation plans and the related tax impacts | 7,167 |
| Payments for contingent consideration | 15,505 |
| Dividends paid | 60,268 |
| Excise tax paid on repurchase of common stock | 1,894 |
| Net cash provided by (used in) financing activities from continuing operations | 611,539 |
| Net cash provided by operating activities | 243,995 |
| Net cash used in investing activities | -36,538 |
| Net cash provided by (used in) discontinued operations | 207,457 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | 23,174 |
| Net increase (decrease) in cash, cash equivalents and restricted cash equivalents | 126,199 |
TELEFLEX INC (TFX)
TELEFLEX INC (TFX)